| Stage | ON | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $96.2B | 100.00% | NVDA ×60.01 |
| Gross profit | $616M | 38.43% | $72.1B | 74.98% | NVDA +36.5pp |
| Operating income | $259M | 16.13% | $63.7B | 66.24% | NVDA +50.1pp |
| Pre-tax income | $271M | 16.89% | $71.5B | 74.32% | NVDA +57.4pp |
| Net income | $228M | 14.19% | $59.7B | 62.03% | NVDA +47.8pp |
| Stage | ON | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $96.2B100.00% | NVDA ×60.01 |
| Gross profit | 38.43%$616M | 74.98%$72.1B | NVDA +36.5pp |
| Operating income | 16.13%$259M | 66.24%$63.7B | NVDA +50.1pp |
| Pre-tax income | 16.89%$271M | 74.32%$71.5B | NVDA +57.4pp |
| Net income |
| 14.19%$228M |
| 62.03%$59.7B |
| NVDA +47.8pp |
No shared counterparties.